- IN₹1.07tn
- IN₹973.06bn
- IN₹281.63bn
Lilly targets India as global export hub amid booming Mounjaro sales, executive says (updated)
Lilly targets India as global export hub amid booming Mounjaro sales, executive says
Biocon aims for revenue surge with rollout of generic weight-loss drugs
Biocon aims for revenue surge with rollout of generic weight-loss drugs
Brief: Cipla Says USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
India's Aurobindo Pharma posts higher profit on steady domestic demand
Brief: Cipla Says Tax Department Initiates Inspection At Cipla Facilities
Drugmaker Alembic Pharma posts earnings dip on Indian labour code changes
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Indian drugmaker Cipla falls on JPM downgrade to "neutral"
Indian drugmaker Cipla's quarterly profit falls 57% on key drug supply crunch (updated)
India's Cipla drops to lowest since May 2024 on quarterly profit miss
Indian drugmaker Cipla misses third-quarter profit view
Brief: Cipla Q3 Consol Net Profit 6.76 Billion Rupees
Preview: India's Cipla climbs; analysts upbeat on domestic earnings, cautious on US
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
India's Cipla top loser on Nifty 50 after brokerages cut ratings on earnings risk
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Generic Advair nod helps India's Aurobindo Pharma, raises competition for Cipla, Citi says